2. Signaling Pathways
  3. Apoptosis
  4. TNF Receptor
  5. TNFRSF8/CD30 Isoform
  6. TNFRSF8/CD30 Inhibitor

TNFRSF8/CD30 Inhibitor

TNFRSF8/CD30 Inhibitor (1):

Cat. No. Product Name Effect Purity
  • HY-P99151
    Brentuximab
    		Inhibitor 98.99%
    Brentuximab is a monoclonal antibody targeting CD30. Brentuximab is conjugated with monomethyl auristatin E (MMAE) (HY-15162) to form the antibody-drug conjugate Brentuximab vedotin (HY-P99107), which can induce apoptosis in primary effusion lymphoma cells. Brentuximab vedotin exhibits antitumor activity with an IC50 of 10 nM against human CD30+ cancer cells.